Application note: Benchmarking the Microsart® AMP Mycoplasma kit against products from two other suppliers
Posted: 2 May 2019 | Sartorius | No comments yet
This application note compares Sartorius’ Microsart AMP Mycoplasma kit with two other mycoplasma detection kits that are also based on DNA isolation with subsequent real-time PCR analysis.
Among the world’s smallest bacteria, mycoplasmas are capable of independent reproduction. They belong to the class of mollicutes and have a very slow parasitic growth. The contamination of cell cultures remains a major problem. An array of physiological and biochemical parameters are affected by the presence of mycoplasma in cells cultures. The infection causes changes in metabolism, growth, viability, macromolecule synthesis, morphology, etc, and therefore a sensitive routine testing for contamination of cell cultures is essential.
READ THE APPLICATION NOTE HERE
Related content from this organisation
- Enhancing efficiency and economics in process development and biotherapeutics
- Pharmaceutical membrane filtration market to value $10 billion by 2025
- Cell line development services market to value $2.4 billion by 2030
- Microbial air sampler market to value $545mn by 2028
- Pharmaceutical QC market to value $9,700mn by 2027